Search results
Syrian first lady Asma Assad diagnosed with leukemia, president’s office says - WTOP News
WTOP Washington· 6 days agoSyrian first lady Asma Assad has been diagnosed with leukemia, the office of President Bashar Assad announced Tuesday. The president’s wife was diagnosed with acute ...
Boy who died at 15 to become first millennial saint in Catholic Church: What did he do?
WJW via Yahoo News· 2 days agoHe had also considered priesthood, his mother said, before becoming sick and dying after a battle...
Syrian first lady Asma Assad diagnosed with leukemia, president's office says
KEYT 3 Santa Barbara· 6 days agoThe office of President Bashar Assad has announced that Syrian first lady Asma Assad has been...
In the news | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 5 days agoAsma Assad, wife of Syrian President Bashar Assad, was diagnosed with acute myeloid leukemia -- an aggressive cancer of the bone marrow ...
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 4 days agoStockNews.com assumed coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 16 hours agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.94
ETF DAILY NEWS· 5 days agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports.
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates PR Newswire SUZHOU, China and ROCKVILLE, Md., May 23, 2024 SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma
Incyte (NASDAQ:INCY) Coverage Initiated at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 2 days agoEquities research analysts at Deutsche Bank Aktiengesellschaft began coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research note issued to investors on Thursday, MarketBeat ...
